Charles Elliott Sigal

Insider Reports History

Location
32 Brearly Road, Princeton, NJ
Signature
By: Brett Budzinski, Attorney-in-Fact For: Charles Elliott Sigal
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles Elliott Sigal:

Insider Reports Filed by Charles Elliott Sigal

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALNY ALNYLAM PHARMACEUTICALS, INC. May 8, 2025 2 $0 4 May 12, 2025 Director
VIR Vir Biotechnology, Inc. May 30, 2024 2 $0 4 Jun 3, 2024 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. May 16, 2024 1 $0 4 May 20, 2024 Director
SURF Surface Oncology, Inc. Sep 8, 2023 2 $0 4 Sep 8, 2023 Director
ADAP Adaptimmune Therapeutics PLC Jul 3, 2023 1 $0 4 Jul 3, 2023 Director
VIR Vir Biotechnology, Inc. May 22, 2023 2 $0 4 May 24, 2023 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. May 18, 2023 1 $0 4 May 19, 2023 Director
VIR Vir Biotechnology, Inc. Mar 1, 2023 1 $56.8K 4 Mar 2, 2023 Director
VIR Vir Biotechnology, Inc. Jan 5, 2023 1 $62.4K 4 Jan 9, 2023 Director
VIR Vir Biotechnology, Inc. Jan 3, 2023 2 $127K 4 Jan 5, 2023 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Aug 22, 2022 1 $0 4 Aug 24, 2022 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Aug 22, 2022 0 $0 3 Aug 24, 2022 Director
ADAP Adaptimmune Therapeutics PLC Jul 1, 2022 1 $0 4 Jul 1, 2022 Director
SURF Surface Oncology, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
VIR Vir Biotechnology, Inc. May 23, 2022 2 $0 4 May 25, 2022 Director
ADAP Adaptimmune Therapeutics PLC Jul 1, 2021 1 $0 4 Jul 2, 2021 Director
SURF Surface Oncology, Inc. Jun 8, 2021 1 $0 4 Jun 10, 2021 Director
VIR Vir Biotechnology, Inc. May 21, 2021 2 $0 4 May 25, 2021 Director